ZENLABS ETHICA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.17 INR | +5.00% |
|
+10.17% | +9.11% |
| Sales 2022 | 691M 8.29M | Sales 2023 | 669M 8.03M | Capitalization | 450M 5.4M |
|---|---|---|---|---|---|
| Net income 2022 | 8M 96.04K | Net income 2023 | 4M 48.02K | EV / Sales 2022 | 0.3 x |
| Net Debt 2022 | 23.95M 288K | Net Debt 2023 | 42.26M 507K | EV / Sales 2023 | 0.74 x |
| P/E ratio 2022 |
22.6
x | P/E ratio 2023 |
92.1
x | Employees | 69 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 40.71% |
More Fundamentals
* Assessed data
More news
| 1 day | +5.00% | ||
| 1 week | +10.17% | ||
| Current month | +8.84% | ||
| 1 month | +7.91% | ||
| 3 months | -14.64% | ||
| 6 months | +27.38% | ||
| Current year | +9.11% |
1 week
39.52
45.17
1 month
38.8545.17
Current year
38.8570.00
1 year
31.3070.00
3 years
21.5083.00
5 years
17.9083.00
10 years
6.79134.90
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 05-03-14 | |
Adarsh Sharma
DFI | Director of Finance/CFO | - | 23-07-27 |
Akshay Saxena
CMP | Compliance Officer | - | 23-07-27 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 05-03-14 | |
Him Jyoti
BRD | Director/Board Member | - | 15-03-24 |
Sanjay Dhir
BRD | Director/Board Member | 53 | 16-08-10 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 45.17 | +5.00% | 27 534 |
| 24-04-25 | 43.02 | +4.95% | 15,976 |
| 24-04-24 | 40.99 | -0.02% | 4,363 |
| 24-04-23 | 41 | -1.18% | 1,477 |
| 24-04-22 | 41.49 | +1.20% | 4,625 |
Delayed Quote Bombay S.E., April 26, 2024 at 06:28 am EDT
More quotes
Zenlabs Ethica Limited is an India-based marketing company. The Company is engaged in trading in a range of branded drugs, including gastrointestinal tract disorders, anti-diabetics, anti-hypertensive drugs, anti-infective, soaps and anti-bacterial drugs, nutraceuticals, and other. It has approximately five manufacturing units. It operates through three divisions: Zenlabs, Coles Pharma and Mega Star. Zenlabs division provides various products, including Analgesics & Anti-Inflammatory, Skin Preparations, Neurological Disorders, Eye, Ear and Nasal Drops, Anti-Diabetic, Anti-Depressant, Anti-Infective, Anti-Emetic, Steroid & Anabolic Steroid, Anti-Hypertensive Drugs, Anti Allergic, Anti Cold & Cough Syrup, Nutraceuticals, Antacid, Enzymes & Appetite Stimulant, Ayurvedic Preparation, GIT Disorders, Soap, and Other Pharmaceutical Drugs. Coles Pharma division provides various products, including Analgesics & Anti-Inflammatory, Nutraceuticals, Skin Preparations, and other.
Sector
Pharmaceuticals
Calendar
2024-05-21
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +9.11% | 3.36M | |
| +16.62% | 70.95B | |
| +2.99% | 25.25B | |
| +5.38% | 8.67B | |
| +6.46% | 8.16B | |
| -21.01% | 7.91B | |
| -0.18% | 4.51B | |
| +17.12% | 4.31B | |
| -0.14% | 4.07B | |
| -3.51% | 3.84B |
- Stock Market
- Equities
- ZENLABS6 Stock
